The future of MS biomarkers: key takeaways from ACTRIMS 2022

ACTRIMS 2022 highlighted novel scientific discoveries for multiple sclerosis (MS), with a focus on MS biomarkers. Read key takeaways from Peter Ngum, Combinostics Clinical Application Specialist, from better, novel treatments to the potential of enhanced AI-based neuroimaging for improved patient management.

Continue ReadingThe future of MS biomarkers: key takeaways from ACTRIMS 2022

Meet the Team: Peter Ngum, Clinical Application Specialist

In the third edition of our “Meet the Team” blog series, we talk to Peter Ngum, one of Combinostics’ Clinical Application Specialists, about his academic and industry experience, what he loves about his role, and some fascinating conferences he’s attended recently.

Continue ReadingMeet the Team: Peter Ngum, Clinical Application Specialist